Entrada Therapeutics, Inc.TRDA
Close of Friday, October 23, 2026 · Entrada Therapeutics, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$4.41
vs its Pivot
-50.5%
OnlyAlpha Score
35
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -29.1% | -57.1% | -30.1% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.01%IWM · 0.01%
Big investors that own it (latest 13F)
| Baker Bros. Advisors | 0.2% of holdings |
Get TRDA in your free daily emailAfter every close: whether TRDA is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track TRDA free → Full Stock check
Track TRDA free → Full Stock check